Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) EBIT (2016 - 2025)

Historic EBIT for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to -$17.0 million.

  • Orthofix Medical's EBIT rose 980.48% to -$17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$93.4 million, marking a year-over-year decrease of 212.34%. This contributed to the annual value of -$84.6 million for FY2024, which is 3917.12% up from last year.
  • According to the latest figures from Q3 2025, Orthofix Medical's EBIT is -$17.0 million, which was up 980.48% from -$16.0 million recorded in Q2 2025.
  • Orthofix Medical's EBIT's 5-year high stood at $6.6 million during Q2 2022, with a 5-year trough of -$59.7 million in Q1 2023.
  • Over the past 5 years, Orthofix Medical's median EBIT value was -$16.0 million (recorded in 2025), while the average stood at -$17.2 million.
  • Its EBIT has fluctuated over the past 5 years, first surged by 12031.9% in 2021, then tumbled by 184002.6% in 2023.
  • Quarter analysis of 5 years shows Orthofix Medical's EBIT stood at -$9.4 million in 2021, then dropped by 18.08% to -$11.0 million in 2022, then plummeted by 65.84% to -$18.3 million in 2023, then surged by 37.34% to -$11.5 million in 2024, then tumbled by 48.52% to -$17.0 million in 2025.
  • Its EBIT was -$17.0 million in Q3 2025, compared to -$16.0 million in Q2 2025 and -$48.9 million in Q1 2025.